nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2E1—prostate cancer	0.133	0.382	CbGaD
Proguanil—CYP2C19—prostate cancer	0.132	0.378	CbGaD
Proguanil—CYP3A4—prostate cancer	0.0837	0.24	CbGaD
Proguanil—CYP2C19—Bicalutamide—prostate cancer	0.0269	0.0612	CbGbCtD
Proguanil—CYP2C19—Nilutamide—prostate cancer	0.0269	0.0612	CbGbCtD
Proguanil—CYP2E1—Estrone—prostate cancer	0.0257	0.0585	CbGbCtD
Proguanil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0247	0.0563	CbGbCtD
Proguanil—CYP2C9—Bicalutamide—prostate cancer	0.0223	0.0509	CbGbCtD
Proguanil—CYP2C9—Nilutamide—prostate cancer	0.0223	0.0509	CbGbCtD
Proguanil—CYP2C19—Flutamide—prostate cancer	0.0223	0.0507	CbGbCtD
Proguanil—CYP1A2—Flutamide—prostate cancer	0.0205	0.0468	CbGbCtD
Proguanil—CYP2D6—Bicalutamide—prostate cancer	0.0204	0.0465	CbGbCtD
Proguanil—CYP2D6—Abiraterone—prostate cancer	0.0169	0.0386	CbGbCtD
Proguanil—CYP2E1—Mitoxantrone—prostate cancer	0.0153	0.0348	CbGbCtD
Proguanil—CYP1A2—Estrone—prostate cancer	0.0149	0.0338	CbGbCtD
Proguanil—CYP2C9—Estrone—prostate cancer	0.0134	0.0305	CbGbCtD
Proguanil—CYP3A4—Bicalutamide—prostate cancer	0.013	0.0296	CbGbCtD
Proguanil—CYP3A4—Estramustine—prostate cancer	0.0121	0.0275	CbGbCtD
Proguanil—CYP3A4—Flutamide—prostate cancer	0.0108	0.0245	CbGbCtD
Proguanil—CYP3A4—Abiraterone—prostate cancer	0.0108	0.0245	CbGbCtD
Proguanil—CYP2C9—Capecitabine—prostate cancer	0.0101	0.0231	CbGbCtD
Proguanil—CYP1A2—Conjugated Estrogens—prostate cancer	0.00972	0.0221	CbGbCtD
Proguanil—CYP2E1—Etoposide—prostate cancer	0.00963	0.0219	CbGbCtD
Proguanil—CYP2C19—Estradiol—prostate cancer	0.00925	0.0211	CbGbCtD
Proguanil—CYP1A2—Estradiol—prostate cancer	0.00853	0.0194	CbGbCtD
Proguanil—CYP3A4—Cabazitaxel—prostate cancer	0.00796	0.0181	CbGbCtD
Proguanil—CYP2C19—Prednisone—prostate cancer	0.00795	0.0181	CbGbCtD
Proguanil—CYP3A4—Estrone—prostate cancer	0.00778	0.0177	CbGbCtD
Proguanil—CYP2C9—Estradiol—prostate cancer	0.00769	0.0175	CbGbCtD
Proguanil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00694	0.0158	CbGbCtD
Proguanil—CYP1A2—Etoposide—prostate cancer	0.00557	0.0127	CbGbCtD
Proguanil—CYP3A4—Conjugated Estrogens—prostate cancer	0.00509	0.0116	CbGbCtD
Proguanil—CYP3A4—Mitoxantrone—prostate cancer	0.00463	0.0105	CbGbCtD
Proguanil—CYP3A4—Estradiol—prostate cancer	0.00447	0.0102	CbGbCtD
Proguanil—CYP3A4—Prednisone—prostate cancer	0.00384	0.00876	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—prostate cancer	0.00313	0.00713	CbGbCtD
Proguanil—CYP3A4—Etoposide—prostate cancer	0.00292	0.00665	CbGbCtD
Proguanil—CYP3A4—Docetaxel—prostate cancer	0.00267	0.00608	CbGbCtD
Proguanil—CYP2C19—urine—prostate cancer	0.00267	0.113	CbGeAlD
Proguanil—CYP1A2—urine—prostate cancer	0.00218	0.0922	CbGeAlD
Proguanil—CYP2C9—urine—prostate cancer	0.00207	0.0875	CbGeAlD
Proguanil—CYP3A4—Doxorubicin—prostate cancer	0.00199	0.00453	CbGbCtD
Proguanil—CYP2E1—urine—prostate cancer	0.00196	0.0829	CbGeAlD
Proguanil—DHFR—prostate gland—prostate cancer	0.00169	0.0712	CbGeAlD
Proguanil—CYP3A4—urine—prostate cancer	0.00158	0.0667	CbGeAlD
Proguanil—CYP2D6—urine—prostate cancer	0.00155	0.0657	CbGeAlD
Proguanil—DHFR—seminal vesicle—prostate cancer	0.00143	0.0602	CbGeAlD
Proguanil—DHFR—renal system—prostate cancer	0.00115	0.0485	CbGeAlD
Proguanil—DHFR—urethra—prostate cancer	0.00113	0.0477	CbGeAlD
Proguanil—DHFR—bone marrow—prostate cancer	0.000869	0.0367	CbGeAlD
Proguanil—DHFR—testis—prostate cancer	0.000743	0.0314	CbGeAlD
Proguanil—CYP2E1—prostate gland—prostate cancer	0.000704	0.0298	CbGeAlD
Proguanil—CYP2E1—seminal vesicle—prostate cancer	0.000596	0.0252	CbGeAlD
Proguanil—DHFR—lymph node—prostate cancer	0.000538	0.0227	CbGeAlD
Proguanil—CYP1A2—renal system—prostate cancer	0.000534	0.0226	CbGeAlD
Proguanil—CYP2E1—renal system—prostate cancer	0.00048	0.0203	CbGeAlD
Proguanil—CYP2E1—urethra—prostate cancer	0.000472	0.0199	CbGeAlD
Proguanil—CYP3A4—renal system—prostate cancer	0.000386	0.0163	CbGeAlD
Proguanil—CYP2D6—renal system—prostate cancer	0.00038	0.0161	CbGeAlD
Proguanil—Headache—Nilutamide—prostate cancer	0.000312	0.00351	CcSEcCtD
Proguanil—Headache—Flutamide—prostate cancer	0.000311	0.0035	CcSEcCtD
Proguanil—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00031	0.0035	CcSEcCtD
Proguanil—CYP2E1—testis—prostate cancer	0.00031	0.0131	CbGeAlD
Proguanil—Pancytopenia—Mitoxantrone—prostate cancer	0.000309	0.00347	CcSEcCtD
Proguanil—Mental disorder—Goserelin—prostate cancer	0.000308	0.00347	CcSEcCtD
Proguanil—Erythema—Goserelin—prostate cancer	0.000306	0.00345	CcSEcCtD
Proguanil—Malnutrition—Goserelin—prostate cancer	0.000306	0.00345	CcSEcCtD
Proguanil—Mental disorder—Conjugated Estrogens—prostate cancer	0.000306	0.00344	CcSEcCtD
Proguanil—Diarrhoea—Degarelix—prostate cancer	0.000304	0.00343	CcSEcCtD
Proguanil—Malnutrition—Conjugated Estrogens—prostate cancer	0.000304	0.00342	CcSEcCtD
Proguanil—Erythema—Conjugated Estrogens—prostate cancer	0.000304	0.00342	CcSEcCtD
Proguanil—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000298	0.00336	CcSEcCtD
Proguanil—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000298	0.00335	CcSEcCtD
Proguanil—Nausea—Nilutamide—prostate cancer	0.000296	0.00333	CcSEcCtD
Proguanil—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000295	0.00332	CcSEcCtD
Proguanil—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000295	0.00332	CcSEcCtD
Proguanil—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000295	0.00332	CcSEcCtD
Proguanil—Nausea—Flutamide—prostate cancer	0.000295	0.00332	CcSEcCtD
Proguanil—Hepatobiliary disease—Estradiol—prostate cancer	0.000294	0.00331	CcSEcCtD
Proguanil—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000294	0.00331	CcSEcCtD
Proguanil—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000293	0.0033	CcSEcCtD
Proguanil—Diarrhoea—Cabazitaxel—prostate cancer	0.000287	0.00323	CcSEcCtD
Proguanil—Body temperature increased—Bicalutamide—prostate cancer	0.000284	0.0032	CcSEcCtD
Proguanil—Abdominal pain—Bicalutamide—prostate cancer	0.000284	0.0032	CcSEcCtD
Proguanil—Vomiting—Degarelix—prostate cancer	0.000283	0.00319	CcSEcCtD
Proguanil—Stomatitis—Mitoxantrone—prostate cancer	0.000282	0.00318	CcSEcCtD
Proguanil—Rash—Degarelix—prostate cancer	0.000281	0.00316	CcSEcCtD
Proguanil—Dermatitis—Degarelix—prostate cancer	0.00028	0.00316	CcSEcCtD
Proguanil—Headache—Degarelix—prostate cancer	0.000279	0.00314	CcSEcCtD
Proguanil—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000278	0.00313	CcSEcCtD
Proguanil—Cough—Goserelin—prostate cancer	0.000267	0.00301	CcSEcCtD
Proguanil—Vomiting—Cabazitaxel—prostate cancer	0.000267	0.003	CcSEcCtD
Proguanil—Cough—Conjugated Estrogens—prostate cancer	0.000265	0.00298	CcSEcCtD
Proguanil—Nausea—Degarelix—prostate cancer	0.000264	0.00298	CcSEcCtD
Proguanil—Headache—Cabazitaxel—prostate cancer	0.000263	0.00296	CcSEcCtD
Proguanil—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000262	0.00295	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000259	0.00292	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000257	0.00289	CcSEcCtD
Proguanil—Pancytopenia—Etoposide—prostate cancer	0.000257	0.00289	CcSEcCtD
Proguanil—Immune system disorder—Estradiol—prostate cancer	0.000252	0.00284	CcSEcCtD
Proguanil—Mediastinal disorder—Estradiol—prostate cancer	0.000252	0.00283	CcSEcCtD
Proguanil—Nausea—Cabazitaxel—prostate cancer	0.000249	0.0028	CcSEcCtD
Proguanil—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000249	0.0028	CcSEcCtD
Proguanil—Diarrhoea—Bicalutamide—prostate cancer	0.000246	0.00277	CcSEcCtD
Proguanil—CYP2D6—testis—prostate cancer	0.000246	0.0104	CbGeAlD
Proguanil—Nervous system disorder—Goserelin—prostate cancer	0.000245	0.00276	CcSEcCtD
Proguanil—Mental disorder—Estradiol—prostate cancer	0.000245	0.00275	CcSEcCtD
Proguanil—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000243	0.00274	CcSEcCtD
Proguanil—Malnutrition—Estradiol—prostate cancer	0.000243	0.00274	CcSEcCtD
Proguanil—Erythema—Estradiol—prostate cancer	0.000243	0.00274	CcSEcCtD
Proguanil—Skin disorder—Goserelin—prostate cancer	0.000243	0.00274	CcSEcCtD
Proguanil—Skin disorder—Conjugated Estrogens—prostate cancer	0.000241	0.00271	CcSEcCtD
Proguanil—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00024	0.00271	CcSEcCtD
Proguanil—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00024	0.00271	CcSEcCtD
Proguanil—Anorexia—Goserelin—prostate cancer	0.000238	0.00268	CcSEcCtD
Proguanil—Anorexia—Conjugated Estrogens—prostate cancer	0.000236	0.00266	CcSEcCtD
Proguanil—Stomatitis—Etoposide—prostate cancer	0.000235	0.00264	CcSEcCtD
Proguanil—Vomiting—Bicalutamide—prostate cancer	0.000229	0.00257	CcSEcCtD
Proguanil—Hepatobiliary disease—Etoposide—prostate cancer	0.000228	0.00257	CcSEcCtD
Proguanil—Rash—Bicalutamide—prostate cancer	0.000227	0.00255	CcSEcCtD
Proguanil—Dermatitis—Bicalutamide—prostate cancer	0.000227	0.00255	CcSEcCtD
Proguanil—Erythema—Mitoxantrone—prostate cancer	0.000226	0.00255	CcSEcCtD
Proguanil—Headache—Bicalutamide—prostate cancer	0.000225	0.00254	CcSEcCtD
Proguanil—Decreased appetite—Goserelin—prostate cancer	0.000217	0.00245	CcSEcCtD
Proguanil—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000215	0.00243	CcSEcCtD
Proguanil—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000214	0.00241	CcSEcCtD
Proguanil—Nausea—Bicalutamide—prostate cancer	0.000214	0.00241	CcSEcCtD
Proguanil—Pancytopenia—Docetaxel—prostate cancer	0.000213	0.0024	CcSEcCtD
Proguanil—Cough—Estradiol—prostate cancer	0.000212	0.00239	CcSEcCtD
Proguanil—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000208	0.00234	CcSEcCtD
Proguanil—Pancytopenia—Capecitabine—prostate cancer	0.000207	0.00233	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000205	0.00231	CcSEcCtD
Proguanil—Gastrointestinal pain—Goserelin—prostate cancer	0.000205	0.0023	CcSEcCtD
Proguanil—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000203	0.00228	CcSEcCtD
Proguanil—Abdominal pain—Goserelin—prostate cancer	0.000198	0.00223	CcSEcCtD
Proguanil—Body temperature increased—Goserelin—prostate cancer	0.000198	0.00223	CcSEcCtD
Proguanil—Cough—Mitoxantrone—prostate cancer	0.000198	0.00222	CcSEcCtD
Proguanil—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000196	0.00221	CcSEcCtD
Proguanil—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000196	0.00221	CcSEcCtD
Proguanil—Immune system disorder—Etoposide—prostate cancer	0.000195	0.0022	CcSEcCtD
Proguanil—Stomatitis—Docetaxel—prostate cancer	0.000195	0.0022	CcSEcCtD
Proguanil—Mediastinal disorder—Etoposide—prostate cancer	0.000195	0.0022	CcSEcCtD
Proguanil—Nervous system disorder—Estradiol—prostate cancer	0.000194	0.00219	CcSEcCtD
Proguanil—Vomiting—Ethinyl Estradiol—prostate cancer	0.000193	0.00218	CcSEcCtD
Proguanil—Skin disorder—Estradiol—prostate cancer	0.000193	0.00217	CcSEcCtD
Proguanil—Rash—Ethinyl Estradiol—prostate cancer	0.000192	0.00216	CcSEcCtD
Proguanil—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000191	0.00216	CcSEcCtD
Proguanil—Headache—Ethinyl Estradiol—prostate cancer	0.00019	0.00214	CcSEcCtD
Proguanil—Hepatobiliary disease—Docetaxel—prostate cancer	0.000189	0.00213	CcSEcCtD
Proguanil—Stomatitis—Capecitabine—prostate cancer	0.000189	0.00213	CcSEcCtD
Proguanil—Hepatobiliary disease—Capecitabine—prostate cancer	0.000183	0.00206	CcSEcCtD
Proguanil—Nausea—Ethinyl Estradiol—prostate cancer	0.000181	0.00203	CcSEcCtD
Proguanil—Skin disorder—Mitoxantrone—prostate cancer	0.000179	0.00202	CcSEcCtD
Proguanil—Anorexia—Mitoxantrone—prostate cancer	0.000176	0.00198	CcSEcCtD
Proguanil—Decreased appetite—Estradiol—prostate cancer	0.000172	0.00194	CcSEcCtD
Proguanil—Gastrointestinal disorder—Estradiol—prostate cancer	0.000171	0.00193	CcSEcCtD
Proguanil—Diarrhoea—Goserelin—prostate cancer	0.000171	0.00193	CcSEcCtD
Proguanil—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00017	0.00191	CcSEcCtD
Proguanil—Cough—Etoposide—prostate cancer	0.000164	0.00185	CcSEcCtD
Proguanil—Immune system disorder—Docetaxel—prostate cancer	0.000162	0.00183	CcSEcCtD
Proguanil—Gastrointestinal pain—Estradiol—prostate cancer	0.000162	0.00183	CcSEcCtD
Proguanil—Mediastinal disorder—Docetaxel—prostate cancer	0.000162	0.00182	CcSEcCtD
Proguanil—Decreased appetite—Mitoxantrone—prostate cancer	0.000161	0.00181	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000159	0.00179	CcSEcCtD
Proguanil—Vomiting—Goserelin—prostate cancer	0.000159	0.00179	CcSEcCtD
Proguanil—Rash—Goserelin—prostate cancer	0.000158	0.00178	CcSEcCtD
Proguanil—Dermatitis—Goserelin—prostate cancer	0.000158	0.00177	CcSEcCtD
Proguanil—Vomiting—Conjugated Estrogens—prostate cancer	0.000158	0.00177	CcSEcCtD
Proguanil—Mental disorder—Docetaxel—prostate cancer	0.000157	0.00177	CcSEcCtD
Proguanil—Immune system disorder—Capecitabine—prostate cancer	0.000157	0.00177	CcSEcCtD
Proguanil—Mediastinal disorder—Capecitabine—prostate cancer	0.000157	0.00177	CcSEcCtD
Proguanil—Body temperature increased—Estradiol—prostate cancer	0.000157	0.00177	CcSEcCtD
Proguanil—Abdominal pain—Estradiol—prostate cancer	0.000157	0.00177	CcSEcCtD
Proguanil—Headache—Goserelin—prostate cancer	0.000157	0.00176	CcSEcCtD
Proguanil—Malnutrition—Docetaxel—prostate cancer	0.000156	0.00176	CcSEcCtD
Proguanil—Erythema—Docetaxel—prostate cancer	0.000156	0.00176	CcSEcCtD
Proguanil—Rash—Conjugated Estrogens—prostate cancer	0.000156	0.00176	CcSEcCtD
Proguanil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000156	0.00176	CcSEcCtD
Proguanil—Headache—Conjugated Estrogens—prostate cancer	0.000155	0.00175	CcSEcCtD
Proguanil—Hallucination—Prednisone—prostate cancer	0.000154	0.00174	CcSEcCtD
Proguanil—Mental disorder—Capecitabine—prostate cancer	0.000152	0.00172	CcSEcCtD
Proguanil—Erythema—Capecitabine—prostate cancer	0.000152	0.00171	CcSEcCtD
Proguanil—Malnutrition—Capecitabine—prostate cancer	0.000152	0.00171	CcSEcCtD
Proguanil—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000151	0.0017	CcSEcCtD
Proguanil—Skin disorder—Etoposide—prostate cancer	0.000149	0.00168	CcSEcCtD
Proguanil—Nausea—Goserelin—prostate cancer	0.000149	0.00167	CcSEcCtD
Proguanil—Nausea—Conjugated Estrogens—prostate cancer	0.000147	0.00166	CcSEcCtD
Proguanil—Anorexia—Etoposide—prostate cancer	0.000146	0.00165	CcSEcCtD
Proguanil—Abdominal pain—Mitoxantrone—prostate cancer	0.000146	0.00164	CcSEcCtD
Proguanil—Body temperature increased—Mitoxantrone—prostate cancer	0.000146	0.00164	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—prostate cancer	0.000144	0.00162	CcSEcCtD
Proguanil—Immune system disorder—Prednisone—prostate cancer	0.00014	0.00158	CcSEcCtD
Proguanil—Cough—Docetaxel—prostate cancer	0.000137	0.00154	CcSEcCtD
Proguanil—Mental disorder—Prednisone—prostate cancer	0.000136	0.00153	CcSEcCtD
Proguanil—Diarrhoea—Estradiol—prostate cancer	0.000136	0.00153	CcSEcCtD
Proguanil—Erythema—Prednisone—prostate cancer	0.000135	0.00152	CcSEcCtD
Proguanil—Malnutrition—Prednisone—prostate cancer	0.000135	0.00152	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—prostate cancer	0.000134	0.0015	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—prostate cancer	0.000133	0.0015	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—prostate cancer	0.000133	0.00149	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000132	0.00149	CcSEcCtD
Proguanil—Cough—Capecitabine—prostate cancer	0.000132	0.00149	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—prostate cancer	0.000132	0.00148	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000128	0.00144	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—prostate cancer	0.000128	0.00144	CcSEcCtD
Proguanil—Diarrhoea—Mitoxantrone—prostate cancer	0.000126	0.00142	CcSEcCtD
Proguanil—Vomiting—Estradiol—prostate cancer	0.000126	0.00142	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—prostate cancer	0.000126	0.00142	CcSEcCtD
Proguanil—Nervous system disorder—Docetaxel—prostate cancer	0.000125	0.00141	CcSEcCtD
Proguanil—Rash—Estradiol—prostate cancer	0.000125	0.00141	CcSEcCtD
Proguanil—Dermatitis—Estradiol—prostate cancer	0.000125	0.00141	CcSEcCtD
Proguanil—Headache—Estradiol—prostate cancer	0.000124	0.0014	CcSEcCtD
Proguanil—Skin disorder—Docetaxel—prostate cancer	0.000124	0.0014	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—prostate cancer	0.000122	0.00137	CcSEcCtD
Proguanil—Anorexia—Docetaxel—prostate cancer	0.000122	0.00137	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—prostate cancer	0.000121	0.00137	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—prostate cancer	0.000121	0.00137	CcSEcCtD
Proguanil—Nervous system disorder—Capecitabine—prostate cancer	0.000121	0.00137	CcSEcCtD
Proguanil—Skin disorder—Capecitabine—prostate cancer	0.00012	0.00135	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000118	0.00133	CcSEcCtD
Proguanil—Anorexia—Capecitabine—prostate cancer	0.000118	0.00133	CcSEcCtD
Proguanil—Nausea—Estradiol—prostate cancer	0.000118	0.00133	CcSEcCtD
Proguanil—Vomiting—Mitoxantrone—prostate cancer	0.000117	0.00132	CcSEcCtD
Proguanil—Rash—Mitoxantrone—prostate cancer	0.000116	0.00131	CcSEcCtD
Proguanil—Dermatitis—Mitoxantrone—prostate cancer	0.000116	0.00131	CcSEcCtD
Proguanil—Headache—Mitoxantrone—prostate cancer	0.000116	0.0013	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000114	0.00128	CcSEcCtD
Proguanil—Decreased appetite—Docetaxel—prostate cancer	0.000111	0.00125	CcSEcCtD
Proguanil—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00011	0.00124	CcSEcCtD
Proguanil—Nausea—Mitoxantrone—prostate cancer	0.00011	0.00124	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—prostate cancer	0.00011	0.00123	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—prostate cancer	0.000109	0.00123	CcSEcCtD
Proguanil—Nervous system disorder—Prednisone—prostate cancer	0.000108	0.00122	CcSEcCtD
Proguanil—Decreased appetite—Capecitabine—prostate cancer	0.000107	0.00121	CcSEcCtD
Proguanil—Skin disorder—Prednisone—prostate cancer	0.000107	0.0012	CcSEcCtD
Proguanil—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000107	0.0012	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—prostate cancer	0.000106	0.0012	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—prostate cancer	0.000106	0.00119	CcSEcCtD
Proguanil—Erythema—Epirubicin—prostate cancer	0.000106	0.00119	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—prostate cancer	0.000105	0.00118	CcSEcCtD
Proguanil—Anorexia—Prednisone—prostate cancer	0.000105	0.00118	CcSEcCtD
Proguanil—Gastrointestinal pain—Docetaxel—prostate cancer	0.000104	0.00118	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—prostate cancer	0.000101	0.00114	CcSEcCtD
Proguanil—Gastrointestinal pain—Capecitabine—prostate cancer	0.000101	0.00114	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—prostate cancer	0.000101	0.00114	CcSEcCtD
Proguanil—Abdominal pain—Docetaxel—prostate cancer	0.000101	0.00114	CcSEcCtD
Proguanil—Body temperature increased—Docetaxel—prostate cancer	0.000101	0.00114	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—prostate cancer	9.83e-05	0.00111	CcSEcCtD
Proguanil—Abdominal pain—Capecitabine—prostate cancer	9.78e-05	0.0011	CcSEcCtD
Proguanil—Body temperature increased—Capecitabine—prostate cancer	9.78e-05	0.0011	CcSEcCtD
Proguanil—Vomiting—Etoposide—prostate cancer	9.77e-05	0.0011	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—prostate cancer	9.77e-05	0.0011	CcSEcCtD
Proguanil—Erythema—Doxorubicin—prostate cancer	9.77e-05	0.0011	CcSEcCtD
Proguanil—Rash—Etoposide—prostate cancer	9.69e-05	0.00109	CcSEcCtD
Proguanil—Dermatitis—Etoposide—prostate cancer	9.68e-05	0.00109	CcSEcCtD
Proguanil—Headache—Etoposide—prostate cancer	9.63e-05	0.00108	CcSEcCtD
Proguanil—Decreased appetite—Prednisone—prostate cancer	9.58e-05	0.00108	CcSEcCtD
Proguanil—Cough—Epirubicin—prostate cancer	9.21e-05	0.00104	CcSEcCtD
Proguanil—Nausea—Etoposide—prostate cancer	9.13e-05	0.00103	CcSEcCtD
Proguanil—Gastrointestinal pain—Prednisone—prostate cancer	9.01e-05	0.00101	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.92e-05	0.001	CcSEcCtD
Proguanil—Diarrhoea—Docetaxel—prostate cancer	8.74e-05	0.000984	CcSEcCtD
Proguanil—Body temperature increased—Prednisone—prostate cancer	8.71e-05	0.000981	CcSEcCtD
Proguanil—Abdominal pain—Prednisone—prostate cancer	8.71e-05	0.000981	CcSEcCtD
Proguanil—Cough—Doxorubicin—prostate cancer	8.52e-05	0.00096	CcSEcCtD
Proguanil—Diarrhoea—Capecitabine—prostate cancer	8.46e-05	0.000953	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—prostate cancer	8.45e-05	0.000951	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—prostate cancer	8.37e-05	0.000942	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.26e-05	0.00093	CcSEcCtD
Proguanil—Anorexia—Epirubicin—prostate cancer	8.21e-05	0.000925	CcSEcCtD
Proguanil—Vomiting—Docetaxel—prostate cancer	8.12e-05	0.000914	CcSEcCtD
Proguanil—Rash—Docetaxel—prostate cancer	8.05e-05	0.000907	CcSEcCtD
Proguanil—Dermatitis—Docetaxel—prostate cancer	8.05e-05	0.000906	CcSEcCtD
Proguanil—Headache—Docetaxel—prostate cancer	8e-05	0.000901	CcSEcCtD
Proguanil—Vomiting—Capecitabine—prostate cancer	7.86e-05	0.000885	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—prostate cancer	7.82e-05	0.00088	CcSEcCtD
Proguanil—Rash—Capecitabine—prostate cancer	7.8e-05	0.000878	CcSEcCtD
Proguanil—Dermatitis—Capecitabine—prostate cancer	7.79e-05	0.000877	CcSEcCtD
Proguanil—Headache—Capecitabine—prostate cancer	7.75e-05	0.000872	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—prostate cancer	7.74e-05	0.000872	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—prostate cancer	7.6e-05	0.000856	CcSEcCtD
Proguanil—Nausea—Docetaxel—prostate cancer	7.59e-05	0.000854	CcSEcCtD
Proguanil—Diarrhoea—Prednisone—prostate cancer	7.54e-05	0.000849	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—prostate cancer	7.49e-05	0.000843	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—prostate cancer	7.44e-05	0.000838	CcSEcCtD
Proguanil—Nausea—Capecitabine—prostate cancer	7.35e-05	0.000827	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—prostate cancer	7.04e-05	0.000793	CcSEcCtD
Proguanil—Vomiting—Prednisone—prostate cancer	7e-05	0.000789	CcSEcCtD
Proguanil—Rash—Prednisone—prostate cancer	6.94e-05	0.000782	CcSEcCtD
Proguanil—Dermatitis—Prednisone—prostate cancer	6.94e-05	0.000781	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—prostate cancer	6.93e-05	0.00078	CcSEcCtD
Proguanil—Headache—Prednisone—prostate cancer	6.9e-05	0.000777	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.88e-05	0.000775	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—prostate cancer	6.81e-05	0.000767	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—prostate cancer	6.81e-05	0.000767	CcSEcCtD
Proguanil—Nausea—Prednisone—prostate cancer	6.54e-05	0.000737	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—prostate cancer	6.52e-05	0.000734	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—prostate cancer	6.3e-05	0.00071	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—prostate cancer	6.3e-05	0.00071	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—prostate cancer	5.89e-05	0.000664	CcSEcCtD
Proguanil—Vomiting—Epirubicin—prostate cancer	5.48e-05	0.000617	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—prostate cancer	5.45e-05	0.000614	CcSEcCtD
Proguanil—Rash—Epirubicin—prostate cancer	5.43e-05	0.000612	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—prostate cancer	5.43e-05	0.000611	CcSEcCtD
Proguanil—Headache—Epirubicin—prostate cancer	5.4e-05	0.000608	CcSEcCtD
Proguanil—Nausea—Epirubicin—prostate cancer	5.12e-05	0.000576	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—prostate cancer	5.07e-05	0.000571	CcSEcCtD
Proguanil—Rash—Doxorubicin—prostate cancer	5.03e-05	0.000566	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—prostate cancer	5.02e-05	0.000565	CcSEcCtD
Proguanil—Headache—Doxorubicin—prostate cancer	4.99e-05	0.000562	CcSEcCtD
Proguanil—Nausea—Doxorubicin—prostate cancer	4.73e-05	0.000533	CcSEcCtD
Proguanil—CYP2E1—Metabolism—ITPR1—prostate cancer	3.77e-06	3.76e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MED12—prostate cancer	3.75e-06	3.75e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PRKACB—prostate cancer	3.75e-06	3.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.73e-06	3.73e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GNG5—prostate cancer	3.72e-06	3.72e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PRKACB—prostate cancer	3.71e-06	3.71e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP17A1—prostate cancer	3.71e-06	3.7e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.71e-06	3.7e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.71e-06	3.7e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.68e-06	3.67e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.66e-06	3.66e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.63e-06	3.62e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—prostate cancer	3.61e-06	3.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA3—prostate cancer	3.59e-06	3.58e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.58e-06	3.57e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—prostate cancer	3.56e-06	3.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA4—prostate cancer	3.55e-06	3.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.55e-06	3.55e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NQO1—prostate cancer	3.54e-06	3.53e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA2—prostate cancer	3.53e-06	3.53e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.52e-06	3.52e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—prostate cancer	3.52e-06	3.51e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA2—prostate cancer	3.5e-06	3.5e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TH—prostate cancer	3.49e-06	3.48e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.47e-06	3.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA2—prostate cancer	3.46e-06	3.46e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.45e-06	3.45e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—LPL—prostate cancer	3.45e-06	3.45e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.43e-06	3.43e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HPGDS—prostate cancer	3.42e-06	3.42e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.42e-06	3.41e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCG5—prostate cancer	3.42e-06	3.41e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—prostate cancer	3.41e-06	3.41e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.4e-06	3.39e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.39e-06	3.39e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.37e-06	3.37e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.34e-06	3.34e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA1—prostate cancer	3.34e-06	3.33e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A1—prostate cancer	3.33e-06	3.33e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—prostate cancer	3.33e-06	3.32e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—prostate cancer	3.32e-06	3.31e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ACHE—prostate cancer	3.32e-06	3.31e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ERCC2—prostate cancer	3.31e-06	3.3e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTO1—prostate cancer	3.3e-06	3.3e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.3e-06	3.3e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NAT2—prostate cancer	3.3e-06	3.3e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.29e-06	3.29e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GGT1—prostate cancer	3.29e-06	3.28e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.28e-06	3.27e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.27e-06	3.26e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.26e-06	3.26e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NQO1—prostate cancer	3.26e-06	3.25e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOA1—prostate cancer	3.24e-06	3.23e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NQO1—prostate cancer	3.23e-06	3.22e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TH—prostate cancer	3.21e-06	3.2e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.19e-06	3.19e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.19e-06	3.19e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TH—prostate cancer	3.18e-06	3.18e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.17e-06	3.17e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PRKACB—prostate cancer	3.17e-06	3.17e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.17e-06	3.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PLCB2—prostate cancer	3.17e-06	3.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—LRP2—prostate cancer	3.17e-06	3.16e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.16e-06	3.15e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.15e-06	3.14e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.14e-06	3.14e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.13e-06	3.13e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.12e-06	3.12e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MTHFR—prostate cancer	3.11e-06	3.1e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—P4HB—prostate cancer	3.11e-06	3.1e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.1e-06	3.09e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.09e-06	3.09e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RXRA—prostate cancer	3.08e-06	3.07e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPARA—prostate cancer	3.05e-06	3.04e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GGT1—prostate cancer	3.02e-06	3.02e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.02e-06	3.02e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GGT1—prostate cancer	3e-06	2.99e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.99e-06	2.99e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA2—prostate cancer	2.99e-06	2.99e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA1—prostate cancer	2.98e-06	2.97e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—COMT—prostate cancer	2.97e-06	2.96e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—prostate cancer	2.95e-06	2.95e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA1—prostate cancer	2.95e-06	2.95e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.94e-06	2.94e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.93e-06	2.93e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.91e-06	2.9e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ITPR1—prostate cancer	2.9e-06	2.9e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MED12—prostate cancer	2.9e-06	2.89e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GNG5—prostate cancer	2.87e-06	2.87e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CAV1—prostate cancer	2.87e-06	2.86e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.86e-06	2.85e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.86e-06	2.85e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RXRA—prostate cancer	2.83e-06	2.83e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RXRA—prostate cancer	2.81e-06	2.8e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.79e-06	2.78e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—prostate cancer	2.79e-06	2.78e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA3—prostate cancer	2.77e-06	2.76e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NQO1—prostate cancer	2.76e-06	2.75e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—prostate cancer	2.74e-06	2.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—COMT—prostate cancer	2.73e-06	2.72e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TH—prostate cancer	2.72e-06	2.71e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—prostate cancer	2.72e-06	2.71e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—prostate cancer	2.71e-06	2.71e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—COMT—prostate cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.7e-06	2.7e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—prostate cancer	2.69e-06	2.69e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.69e-06	2.68e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.68e-06	2.67e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ITPR1—prostate cancer	2.67e-06	2.67e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—LPL—prostate cancer	2.66e-06	2.66e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ITPR1—prostate cancer	2.65e-06	2.64e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.64e-06	2.64e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HPGDS—prostate cancer	2.64e-06	2.64e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.62e-06	2.62e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.61e-06	2.61e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.6e-06	2.6e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.57e-06	2.57e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ACHE—prostate cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—prostate cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GGT1—prostate cancer	2.56e-06	2.56e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ERCC2—prostate cancer	2.55e-06	2.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.53e-06	2.53e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—prostate cancer	2.52e-06	2.52e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA1—prostate cancer	2.52e-06	2.52e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—prostate cancer	2.5e-06	2.5e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—prostate cancer	2.5e-06	2.49e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—prostate cancer	2.47e-06	2.47e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—INS—prostate cancer	2.47e-06	2.47e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.46e-06	2.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PRKACB—prostate cancer	2.45e-06	2.45e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—LPL—prostate cancer	2.45e-06	2.45e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—LPL—prostate cancer	2.43e-06	2.42e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.42e-06	2.42e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CREBBP—prostate cancer	2.42e-06	2.42e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RXRA—prostate cancer	2.4e-06	2.4e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTHFR—prostate cancer	2.4e-06	2.39e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.37e-06	2.36e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPARA—prostate cancer	2.35e-06	2.35e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ERCC2—prostate cancer	2.35e-06	2.34e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.34e-06	2.34e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.33e-06	2.33e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ERCC2—prostate cancer	2.33e-06	2.32e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—COMT—prostate cancer	2.31e-06	2.31e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA2—prostate cancer	2.31e-06	2.31e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—prostate cancer	2.3e-06	2.3e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.3e-06	2.29e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ITPR1—prostate cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.23e-06	2.22e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CAV1—prostate cancer	2.21e-06	2.21e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTHFR—prostate cancer	2.21e-06	2.2e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.2e-06	2.2e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTHFR—prostate cancer	2.19e-06	2.18e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NOS3—prostate cancer	2.17e-06	2.16e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPARA—prostate cancer	2.16e-06	2.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.15e-06	2.15e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPARA—prostate cancer	2.14e-06	2.14e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—prostate cancer	2.14e-06	2.13e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NQO1—prostate cancer	2.13e-06	2.12e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—prostate cancer	2.11e-06	2.11e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.11e-06	2.11e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TH—prostate cancer	2.1e-06	2.09e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—LPL—prostate cancer	2.07e-06	2.07e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.04e-06	2.04e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CAV1—prostate cancer	2.03e-06	2.03e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CAV1—prostate cancer	2.02e-06	2.01e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.01e-06	2.01e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1A1—prostate cancer	2e-06	2e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CB—prostate cancer	2e-06	2e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ERCC2—prostate cancer	1.99e-06	1.98e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—prostate cancer	1.98e-06	1.98e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GGT1—prostate cancer	1.98e-06	1.97e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA1—prostate cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.93e-06	1.92e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.92e-06	1.92e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—INS—prostate cancer	1.91e-06	1.9e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTHFR—prostate cancer	1.87e-06	1.86e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CREBBP—prostate cancer	1.87e-06	1.86e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RXRA—prostate cancer	1.85e-06	1.85e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.84e-06	1.83e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPARA—prostate cancer	1.83e-06	1.83e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—COMT—prostate cancer	1.78e-06	1.78e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—prostate cancer	1.78e-06	1.77e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.77e-06	1.77e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—INS—prostate cancer	1.75e-06	1.75e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ITPR1—prostate cancer	1.75e-06	1.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—INS—prostate cancer	1.74e-06	1.74e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—prostate cancer	1.73e-06	1.73e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CAV1—prostate cancer	1.72e-06	1.72e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CREBBP—prostate cancer	1.72e-06	1.71e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CREBBP—prostate cancer	1.7e-06	1.7e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NOS3—prostate cancer	1.67e-06	1.67e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—prostate cancer	1.65e-06	1.65e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—prostate cancer	1.65e-06	1.65e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.65e-06	1.64e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—prostate cancer	1.63e-06	1.63e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.63e-06	1.63e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.61e-06	1.61e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—LPL—prostate cancer	1.6e-06	1.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.57e-06	1.57e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.55e-06	1.54e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.54e-06	1.54e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NOS3—prostate cancer	1.54e-06	1.54e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ERCC2—prostate cancer	1.53e-06	1.53e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—prostate cancer	1.53e-06	1.53e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NOS3—prostate cancer	1.52e-06	1.52e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—INS—prostate cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CREBBP—prostate cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTHFR—prostate cancer	1.44e-06	1.44e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.42e-06	1.42e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPARA—prostate cancer	1.41e-06	1.41e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.41e-06	1.41e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—prostate cancer	1.41e-06	1.4e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—prostate cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.38e-06	1.38e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—prostate cancer	1.33e-06	1.33e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CAV1—prostate cancer	1.33e-06	1.33e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NOS3—prostate cancer	1.3e-06	1.3e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—prostate cancer	1.27e-06	1.27e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—prostate cancer	1.23e-06	1.22e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.22e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—prostate cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.21e-06	1.21e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.2e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—prostate cancer	1.19e-06	1.19e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—prostate cancer	1.17e-06	1.17e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—prostate cancer	1.16e-06	1.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—INS—prostate cancer	1.15e-06	1.14e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CREBBP—prostate cancer	1.12e-06	1.12e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.06e-06	1.06e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—prostate cancer	1.04e-06	1.04e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NOS3—prostate cancer	1.01e-06	1e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—prostate cancer	9.96e-07	9.95e-06	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—prostate cancer	9.91e-07	9.89e-06	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—prostate cancer	9.41e-07	9.39e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CB—prostate cancer	9.28e-07	9.27e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—prostate cancer	9.2e-07	9.18e-06	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.65e-07	8.64e-06	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—prostate cancer	8.58e-07	8.57e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—prostate cancer	8.02e-07	8.01e-06	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—prostate cancer	7.69e-07	7.67e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—prostate cancer	7.65e-07	7.64e-06	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—prostate cancer	7.33e-07	7.32e-06	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—prostate cancer	7.07e-07	7.06e-06	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—prostate cancer	7.01e-07	7e-06	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—prostate cancer	5.99e-07	5.98e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.66e-07	5.65e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—prostate cancer	4.62e-07	4.61e-06	CbGpPWpGaD
